PRIMATENE Trademark

Trademark Overview

On Wednesday, November 21, 2018, a trademark application was filed for PRIMATENE with the United States Patent and Trademark Office. The USPTO has given the PRIMATENE trademark a serial number of 88202829. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, November 10, 2025. This trademark is owned by ARMSTRONG PHARMACEUTICALS, INC.. The PRIMATENE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for temporary relief of mild symptoms of intermittent asthma
primatene

General Information

Serial Number88202829
Word MarkPRIMATENE
Filing DateWednesday, November 21, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, November 10, 2025
Registration Number5841251
Registration DateTuesday, August 20, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for temporary relief of mild symptoms of intermittent asthma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 11, 2018
Primary Code005
First Use Anywhere DateSaturday, May 29, 1954
First Use In Commerce DateSaturday, May 29, 1954

Trademark Owner History

Party NameARMSTRONG PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCanton, MA 02021
Party NameARMSTRONG PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanton, MA 02021
Party NameARMSTRONG PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanton, MA 02021

Trademark Events

Event DateEvent Description
Saturday, November 24, 2018NEW APPLICATION ENTERED
Tuesday, December 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 21, 2019ASSIGNED TO EXAMINER
Tuesday, February 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 21, 2019TEAS STATEMENT OF USE RECEIVED
Friday, July 12, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 21, 2019USE AMENDMENT FILED
Friday, July 12, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, July 15, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 16, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 20, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, June 14, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 14, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 12, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 20, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 21, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, November 10, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 10, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 10, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

primatene symptoms intermittent asthma mild relief preparations temporary pharmaceutical